Outcomes of concurrent versus sequential icotinib therapy and chemotherapy in advanced non‐small cell lung cancer with sensitive EGFR mutations

ABSTRACT: To explore a better treatment strategy for patients with advanced non‐small cell lung cancer harboring sensitive epidermal growth factor receptor mutations, a total of 271 patients were retrospectively analyzed. The patients were divided into two groups: the combination group (58 cases), w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yun, Wang, Jing, Yu, Zhuang, Ge, Hong, Zhang, Lin‐Wei, Feng, Ling‐Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212732/
https://www.ncbi.nlm.nih.gov/pubmed/33382908
http://dx.doi.org/10.1111/cts.12951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212732/
https://www.ncbi.nlm.nih.gov/pubmed/33382908
http://dx.doi.org/10.1111/cts.12951

Ejemplares similares